AE-C study materials
AE-C study resources

A Dose Counter That Tells a Different Story Than the Patient

AE-C · Put your knowledge to work in context.

All case studies

A Dose Counter That Tells a Different Story Than the Patient

Ms. P is 47 and was diagnosed with asthma two years ago after a prolonged cough. She was prescribed fluticasone propionate 110 mcg, two puffs twice daily, and albuterol two puffs every four to six hours as needed. Today she says the preventer is 'part of my routine, morning and night,' and that she uses albuterol 'maybe twice a week.' The dose counter on the fluticasone canister reads 84 of 120 actuations remaining. The pharmacy fill date on the label is 11 weeks ago. She does not use a spacer. When you watch her demonstrate the fluticasone, she does not shake the canister, actuates the first puff immediately after starting a fast inhalation, and fires the second puff about three seconds later without waiting or holding her breath.

1. What do the counter and the label date tell you, and how would you raise the discrepancy without damaging the relationship?

Read the worked answer

Do the arithmetic out loud. Eleven weeks is roughly 77 days; at four puffs daily the prescription predicts about 308 actuations. The counter shows 36 used. Even allowing a few priming sprays, she is at roughly a tenth to an eighth of prescribed use -- this is objective evidence of non-use, not a rounding error.

Raise it as information, not as a charge. Open with the tool, not the accusation: 'The counter is the most useful thing we have -- it shows what daily life with this inhaler actually looks like, and a lot of people find twice a day hard.' Then ask about barriers in a fixed order rather than waiting: cost, throat irritation or hoarseness, what she believes about steroids, forgetting, and the morning rush.

Her twice-weekly albuterol figure should be treated as unverified too. Two fluently under-reported data points belonging to the same person is one pattern, not two coincidences -- and it means the control question cannot be answered from her history alone.

2. You have fifteen minutes. What do you address first, and why?

Read the worked answer

Address the reason for non-use first and technique second, but do not end the visit without both.

  • Technique corrections matter only in proportion to use. Teaching a perfect inhalation on an inhaler taken once a week changes little; the barriers conversation is what unlocks the drug.
  • Nonetheless, her observed technique is wrong in three ways that each independently cut lung deposition: no shaking (the drug settles), firing against a fast inhalation instead of a slow deep one with a breath hold, and no interval between puffs. Fix these because she will be using it more after today, and because a patient who uses correctly and still gets no benefit starts doubting the drug itself.
  • Pick the two changes with the largest effect for the time available: add a valved holding chamber (which also reduces throat irritation and addresses the hoarseness objection) and use it for one puff at a time with a breath hold. Do not attempt five corrections.
  • Close with a specific, dated follow-up and an explicit counter check at that visit, so the same objective measure can verify your teaching.

3. She asks whether she can drop the daily inhaler and just use albuterol when she feels tight, because 'it works faster.' How do you respond?

Read the worked answer

Take the premise seriously, then correct it. She is right that albuterol relieves symptoms faster -- that is exactly why relying on it is the problem. It does nothing for the underlying inflammation, and frequent reliever use is both a marker of poor control and, over time, a risk factor for attacks. Her pattern of using it while taking almost no controller is the pattern most associated with exacerbation.

Reframe the two inhalers as doing different jobs rather than one being weaker: the reliever opens the airway today, the controller makes the airway less reactive over weeks. Warn her explicitly against the reasonable-sounding plan of stopping the controller once she feels better, since that is the point at which the benefit is being maintained rather than achieved.

Give her a condition for revisiting the regimen: if she uses the controller reliably with a chamber for two to three months and still needs reliever less than twice a week, a step-down can be discussed. That turns the request into a goal rather than a refusal.